COGT MEXC RealStocks
Own real COGT shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:52:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Cogent Biosciences, Inc. (COGT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $27.82, with a market capitalization of $4.77B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $26.36 to $43.73. This page covers its latest market performance, valuation, price trends and company information.
$4.77B | |
$27.81 | |
$28.75 | |
$27.14 | |
$27.85 | |
2.43M | |
2.07M | |
-- | |
$43.73 | |
$26.36 | |
-- | |
2026-09-30 |
Cogent Biosciences, Inc. (COGT) last closed at $27.82 as of 2026-11-19 00:31:00, down 0.11% ($0.03) from the previous close of $27.85.
During the latest regular trading session, COGT traded between $27.14 and $28.75, with a volume of 2.43M shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Cogent Biosciences, Inc. (COGT) moved from $33.54 to $27.82, representing a decline of 17.06% ($5.72).
The stock traded between $26.36 and $34.04 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.41 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 8.4%
COGT is currently trading at $27.82, placing it 8.4% of the way from its 52-week low of $26.36 to its 52-week high of $43.73. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 258 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cogent Biosciences, Inc. (COGT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to COGT, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between COGT shares and USD.
COGT Shares to USD
1.00 COGT shares = 27.818 USD
Calculations are estimates based on the latest available price and are for reference only.